Stockscreener 앱 받기
11.66
4.39%
0.49
시간 외 거래:
11.98
0.32
+2.74%
전일 마감가:
$11.17
열려 있는:
$11.16
하루 거래량:
1.90M
Relative Volume:
0.91
시가총액:
$1.42B
수익:
-
순이익/손실:
$-29.07M
주가수익비율:
-40.21
EPS:
-0.29
순현금흐름:
$-31.85M
1주 성능:
+10.94%
1개월 성능:
+27.43%
6개월 성능:
+68.74%
1년 성능:
+295.93%
1일 변동 폭
$11.06
$11.68
1주일 범위
$10.30
$11.68
52주 변동 폭
$2.36
$11.68
트레비 테라퓨틱스 Stock (TRVI) Company Profile
명칭
Trevi Therapeutics Inc
전화
203-304-2499
주소
195 CHURCH STREET, NEW HAVEN, CT
TRVI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
11.66 | 1.36B | 0 | -29.07M | -31.85M | -0.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
트레비 테라퓨틱스 Stock (TRVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-21 | 개시 | Morgan Stanley | Overweight |
| 2025-07-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-05-28 | 개시 | H.C. Wainwright | Buy |
| 2025-03-10 | 재확인 | Needham | Buy |
| 2025-03-10 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-12-12 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-30 | 개시 | H.C. Wainwright | Buy |
| 2024-08-30 | 개시 | Raymond James | Outperform |
| 2024-06-13 | 개시 | Rodman & Renshaw | Buy |
| 2023-04-12 | 개시 | B. Riley Securities | Buy |
| 2022-11-22 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | BMO Capital Markets | Outperform |
| 2019-06-03 | 개시 | Needham | Buy |
| 2019-06-03 | 개시 | SVB Leerink | Outperform |
| 2019-06-03 | 개시 | Stifel | Buy |
모두보기
트레비 테라퓨틱스 주식(TRVI)의 최신 뉴스
Will Trevi Therapeutics Inc. stock continue upward momentumJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Can Trevi Therapeutics Inc. stock reach $100 price targetWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com
What MACD signals say about Trevi Therapeutics Inc.Trade Ideas & Real-Time Chart Breakout Alerts - newser.com
What high frequency data says about Trevi Therapeutics Inc.Weekly Investment Recap & Free Growth Oriented Trading Recommendations - newser.com
Analyzing drawdowns of Trevi Therapeutics Inc. with statistical tools2025 Top Decliners & Daily Entry Point Alerts - newser.com
Should I hold or sell Trevi Therapeutics Inc. stock in 2025July 2025 Outlook & Scalable Portfolio Growth Methods - newser.com
Using Bollinger Bands to evaluate Trevi Therapeutics Inc.July 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - newser.com
Is now a turning point for Trevi Therapeutics Inc.Quarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Technical signs of recovery in Trevi Therapeutics Inc.2025 Analyst Calls & Fast Entry High Yield Stock Tips - newser.com
Trevi Therapeutics Stock Soars on Clinical Progress and Institutional Backing - AD HOC NEWS
Historical volatility pattern of Trevi Therapeutics Inc. visualizedJuly 2025 PreEarnings & Precise Buy Zone Identification - newser.com
Trevi Therapeutics (NASDAQ:TRVI) Hits New 12-Month HighWhat's Next? - MarketBeat
Does Trevi Therapeutics Inc. show high probability of reboundWeekly Profit Recap & Capital Efficiency Focused Ideas - newser.com
Momentum divergence signals in Trevi Therapeutics Inc. chartJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com
Trevi Therapeutics stock hits all-time high at 11.11 USD By Investing.com - Investing.com Nigeria
Applying sector rotation models to Trevi Therapeutics Inc.2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com
Trevi Therapeutics stock hits all-time high at 11.11 USD - Investing.com
Trevi Therapeutics (TRVI) Projected to Post Earnings on Wednesday - MarketBeat
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
트레비 테라퓨틱스 (TRVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):